BIOA today
$5.56-$0.09 (-1.59%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minLeaning Bullish
5 minSymmetric Triangle
Daily trend turns up above $0.68
Key levels
Resistance$6.50
Resistance$5.93
Support$5.27
Support$4.75
Latest news & SEC filings
AnalystPiper Sandler keeps Overweight rating on Bioage Labs, cuts price target to $40
AnalystBTIG Keeps Buy Rating on Bioage Labs, $40 Target Unchanged
All BIOA news →About BioAge Labs
BioAge Labs is a drug developer focused on metabolic conditions, using insights from aging biology to find new treatments. Its main candidate, BGE-102, is an oral NLRP3 inhibitor in testing for heart and blood vessel disease and for diabetic macular edema. The company also works on treatments that mimic exercise for weight loss and partners with Eli Lilly and Novartis on earlier-stage research.
Based on the company's 10-K filed Mar 24, 2026.
Nasdaq · Healthcare
BioAge Labs, Inc. (BIOA)
What Is the Price Target for BIOA?
SEPT Low Target
$8.00
SEPT Mid Target
$35.00
SEPT High Target
$40.00
Analyst Consensus
$35.00
Is BIOA a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BIOA.
Start Free Trial →Is BIOA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$31.71
12
Moat Score
NONE
3/9
Piotroski Score
4.1
Altman Z-Score
What Is Smart Money Doing with BIOA?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BIOA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
66.21%
FCF Growth YoY
-58.7%
Revenue Trend
UNKNOWN
Dark Pool Trades for BIOA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BIOA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:11:13 | $5.55 | 1,000 | $$6K | SELL |
| 18:11:56 | $5.53 | 1,068 | $$6K | SELL |
| 17:59:15 | $5.56 | 5,000 | $$28K | SELL |
| 17:25:16 | $5.55 | 2,500 | $$14K | SELL |
| 15:50:06 | $5.50 | 1,200 | $$7K | BUY |
5 dark pool trades shown · $$60K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BioAge Labs, Inc. (BIOA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BIOA — frequently asked questions
What is BIOA stock price today?
BioAge Labs, Inc. (BIOA) is at $5.56, down 1.59% (-$0.09) at the Nov 13, 2026 close.
Why is BIOA stock moving today?
Latest BIOA news — Nov 9, 2026: Piper Sandler keeps Overweight rating on Bioage Labs, cuts price target to $40 · Nov 9, 2026: BTIG Keeps Buy Rating on Bioage Labs, $40 Target Unchanged
What is the BIOA price target?
The average analyst price target for BIOA is $35.00, ranging from $8 to $40, based on 5 analysts. Latest: UBS initiates on Oct 12, 2026.
What do analysts rate BIOA?
Analyst ratings for BIOA: 0 Buy, 9 Hold, 0 Sell — consensus Hold.
Did BIOA beat earnings?
BIOA last reported on Nov 5, 2026: EPS -$0.73 vs -$0.68 expected — a miss of 7.4%.
Does BIOA pay a dividend?
BIOA does not currently pay a dividend.
What are BIOA support and resistance levels?
Support: $5.27, $4.75, $4.02. Resistance: $5.93, $6.50.
What are insiders doing with BIOA?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on BIOA?
Nov 9, 2026: Piper Sandler keeps Overweight rating on Bioage Labs, cuts price target to $40 · Nov 9, 2026: BTIG Keeps Buy Rating on Bioage Labs, $40 Target Unchanged